MENU
CORT
AS OF
Feb 4, 02:48 PM (EDT)
Price
$39.62
Change
-$1.08 (-2.65%)
Capitalization
4.28B
14 days until earnings call
Intraday BUY SELL Signals
+Compare
CORT
Stock ticker: NASDAQ
AS OF
Feb 4, 02:48 PM (EDT)
Price
$39.62
Change
-$1.08 (-2.65%)
Capitalization
4.28B

CORT Corcept Therapeutics Forecast, Technical & Fundamental Analysis

Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol... Show more

CORT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
a Summary for CORT with price predictions
Feb 03, 2026

CORT saw its Stochastic Oscillator leaves the overbought zone

The Stochastic Oscillator for CORT moved out of overbought territory on February 02, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 59 similar instances where the indicator exited the overbought zone. In of the 59 cases the stock moved lower. This puts the odds of a downward move at .

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

CORT moved below its 50-day moving average on December 30, 2025 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for CORT crossed bearishly below the 50-day moving average on December 31, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 17 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

The 50-day moving average for CORT moved below the 200-day moving average on January 09, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where CORT declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

CORT broke above its upper Bollinger Band on January 22, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where CORT's RSI Oscillator exited the oversold zone, of 29 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on January 20, 2026. You may want to consider a long position or call options on CORT as a result. In of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for CORT just turned positive on January 22, 2026. Looking at past instances where CORT's MACD turned positive, the stock continued to rise in of 36 cases over the following month. The odds of a continued upward trend are .

Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CORT advanced for three days, in of 312 cases, the price rose further within the following month. The odds of a continued upward trend are .

Fundamental Analysis (Ratings)

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. CORT’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (6.775) is normal, around the industry mean (27.519). P/E Ratio (46.782) is within average values for comparable stocks, (51.491). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (1.893). Dividend Yield (0.000) settles around the average of (0.043) among similar stocks. P/S Ratio (6.579) is also within normal values, averaging (331.843).

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. CORT’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 94, placing this stock better than average.

View a ticker or compare two or three
CORT
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I. Advisor
published Earnings

CORT is expected to report earnings to rise 58.75% to 25 cents per share on February 18

Corcept Therapeutics CORT Stock Earnings Reports
Q4'25
Est.
$0.25
Q3'25
Beat
by $0.03
Q2'25
Beat
by $0.10
Q1'25
Beat
by $0.02
Q4'24
Missed
by $0.12
The last earnings report on November 04 showed earnings per share of 15 cents, beating the estimate of 12 cents. With 77.31K shares outstanding, the current market capitalization sits at 4.28B.
A.I. Advisor
published General Information

General Information

a maker of drugs for the treatment of severe psychiatric and neurological diseases

Industry Biotechnology

Profile
Fundamentals
Details
Industry
Pharmaceuticals Other
Address
149 Commonwealth Drive
Phone
+1 650 327-3270
Employees
352
Web
https://www.corcept.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
NRIIX22.780.12
+0.53%
Nuveen Real Asset Income I
TEMEX19.35-0.01
-0.05%
Franklin Mutual Beacon C
WAYEX17.98-0.01
-0.06%
Waycross Managed Risk Equity Fund
GSRLX12.19-0.09
-0.73%
Goldman Sachs Rising Dividend Gr Instl
TEIHX47.55-0.36
-0.75%
Nuveen Equity Index I

CORT and Stocks

Correlation & Price change

A.I.dvisor indicates that over the last year, CORT has been loosely correlated with VTVT. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if CORT jumps, then VTVT could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CORT
1D Price
Change %
CORT100%
-0.02%
VTVT - CORT
49%
Loosely correlated
+7.52%
TENX - CORT
41%
Loosely correlated
N/A
AGIO - CORT
41%
Loosely correlated
-0.82%
DNLI - CORT
40%
Loosely correlated
-4.22%
ARCT - CORT
37%
Loosely correlated
-0.68%
More